107 related articles for article (PubMed ID: 6653366)
21. Barrett's: do we still need goblet cells for diagnosis?
Lenglinger J; Riegler M
Am J Gastroenterol; 2009 Sep; 104(9):2355-6; author reply 2356-7. PubMed ID: 19727095
[No Abstract] [Full Text] [Related]
22. [5-aminolevulinic acid induced fluorescence for the detection of oesophageal lesions].
Hellmig S; Fölsch UR
Z Gastroenterol; 2002 May; 40(5):379-81. PubMed ID: 12016569
[No Abstract] [Full Text] [Related]
23. [Image analysis of AgNORs in esophageal balloon cytosmears].
Wang DY
Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):30-3. PubMed ID: 8334937
[TBL] [Abstract][Full Text] [Related]
24. [Premalignant and malignant changes in the epithelium in an antethoracic skin tube after esophagus replacement surgery].
Petri A; Petri I; Németh A; Imre J
Chirurg; 1981 Aug; 52(8):501-4. PubMed ID: 7273927
[TBL] [Abstract][Full Text] [Related]
25. Intervention and follow-up on human esophageal precancerous lesions in Henan, northern China, a high-incidence area for esophageal cancer.
Wang LD; Zhou Q; Feng CW; Liu B; Qi YJ; Zhang YR; Gao SS; Fan ZM; Zhou Y; Yang CS; Wei JP; Zheng S
Gan To Kagaku Ryoho; 2002 Feb; 29 Suppl 1():159-72. PubMed ID: 11890101
[TBL] [Abstract][Full Text] [Related]
26. Loss of MAL expression in precancerous lesions of the esophagus.
Mimori K; Nishida K; Nakamura Y; Ieta K; Yoshikawa Y; Sasaki A; Ishii H; Alonso MA; Mori M
Ann Surg Oncol; 2007 May; 14(5):1670-7. PubMed ID: 17151798
[TBL] [Abstract][Full Text] [Related]
27. [Effect of chronic inflammation-induced basement membrane changes on esophageal carcinogenesis].
Zhang GH; Su M; Tian DP
Ai Zheng; 2005 Sep; 24(9):1071-5. PubMed ID: 16159427
[TBL] [Abstract][Full Text] [Related]
28. Gastro-esophageal cytology.
Drake M
Monogr Clin Cytol; 1985; 10():1-267. PubMed ID: 3969074
[No Abstract] [Full Text] [Related]
29. High-resolution chromoendoscopy in the esophagus.
Sidorenko EI; Sharma P
Gastrointest Endosc Clin N Am; 2004 Jul; 14(3):437-51, vii. PubMed ID: 15261194
[TBL] [Abstract][Full Text] [Related]
30. [Topic Complex VI: Barrett esophagus].
Messmann H; Ell C; Fein M; Kiesslich R; Ortner M; Porschen R; Stolte M
Z Gastroenterol; 2005 Feb; 43(2):184-90. PubMed ID: 15700212
[No Abstract] [Full Text] [Related]
31. [Photodynamic therapy of dysplasia and early cancer of the esophagus].
Gossner L; Ell C
Leber Magen Darm; 1996 May; 26(3):132, 135-7. PubMed ID: 8709826
[TBL] [Abstract][Full Text] [Related]
32. It takes two to tango: dance steps for diagnosing Barrett's esophagus.
Rubenstein JH
Gastrointest Endosc; 2009 May; 69(6):1011-3. PubMed ID: 19410039
[No Abstract] [Full Text] [Related]
33. Squamous dysplasia and other precursor lesions related to esophageal squamous cell carcinoma.
Shimizu M; Ban S; Odze RD
Gastroenterol Clin North Am; 2007 Dec; 36(4):797-811, v-vi. PubMed ID: 17996791
[TBL] [Abstract][Full Text] [Related]
34. [Analyzing the profile of chromosomal imbalances in esophageal atypical hyperplasia and early stage esophageal squamous cell carcinoma by 250K Snp Array].
Zhang X; Zhu ZH; Lin P; Yang H; Fu JH; Zhang LJ; Long H; Wen J; Huang XP; Fang Y; Rong TH
Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(37):2636-41. PubMed ID: 19080713
[TBL] [Abstract][Full Text] [Related]
35. [Early esophageal carcinoma: diagnosis and endoscopic therapy].
Ell C
Z Gastroenterol; 2002 Dec; 40 Suppl 2():12-4. PubMed ID: 12466997
[No Abstract] [Full Text] [Related]
36. Genetic mechanisms in esophageal carcinogenesis: frequent deletion of 3p and 17p in premalignant lesions.
Shimada M; Yanagisawa A; Kato Y; Inoue M; Shiozaki H; Monden M; Nakamura Y
Genes Chromosomes Cancer; 1996 Mar; 15(3):165-9. PubMed ID: 8721680
[TBL] [Abstract][Full Text] [Related]
37. [Surgical or conservative therapy of Barrett esophagus?].
Fuchs KH; Engemann R; Thiede A
Chirurg; 1994 Feb; 65(2):88-95. PubMed ID: 7909287
[No Abstract] [Full Text] [Related]
38. [No grounds for Barrett hysteria. Current monitoring strategies are adequately reliable].
Schilling D; Riemann JF
MMW Fortschr Med; 2002 Jul; 144(27-28):40-1. PubMed ID: 12198878
[No Abstract] [Full Text] [Related]
39. [Risk estimation in Barrett's esophagus: biomolecular marker and histopathologic classification].
Walch A; Schmitt-Gräff A; Stein H; Werner M
Zentralbl Chir; 2002 Dec; 127(12):1073-7. PubMed ID: 12529823
[TBL] [Abstract][Full Text] [Related]
40. Endoscopic fluorescence detection of low and high grade dysplasia in Barrett's oesophagus using systemic or local 5-aminolaevulinic acid sensitization.
Eisendrath P; Van Laethem JL
Gastrointest Endosc; 2002 Feb; 55(2):297-8. PubMed ID: 11845793
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
